171 related articles for article (PubMed ID: 20636642)
1. Evidence for cis-acting regulation of ANK3 and CACNA1C gene expression.
Quinn EM; Hill M; Anney R; Gill M; Corvin AP; Morris DW
Bipolar Disord; 2010 Jun; 12(4):440-5. PubMed ID: 20636642
[TBL] [Abstract][Full Text] [Related]
2. ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.
Kloiber S; Czamara D; Karbalai N; Müller-Myhsok B; Hennings J; Holsboer F; Lucae S
J Psychiatr Res; 2012 Aug; 46(8):973-9. PubMed ID: 22647524
[TBL] [Abstract][Full Text] [Related]
3. No association between bipolar disorder risk polymorphisms in ANK3 and CACNA1C and common migraine.
Wöber-Bingöl C; Tropeano M; Karwautz A; Wagner G; Campos-de-Sousa S; Zesch HE; Kienbacher C; Natriashvili S; Kanbur I; Ray M; Wöber C; Collier DA
Headache; 2011 May; 51(5):796-803. PubMed ID: 21395576
[TBL] [Abstract][Full Text] [Related]
4. Independent modulation of engagement and connectivity of the facial network during affect processing by CACNA1C and ANK3 risk genes for bipolar disorder.
Dima D; Jogia J; Collier D; Vassos E; Burdick KE; Frangou S
JAMA Psychiatry; 2013 Dec; 70(12):1303-11. PubMed ID: 24108394
[TBL] [Abstract][Full Text] [Related]
5. ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype.
Lett TA; Zai CC; Tiwari AK; Shaikh SA; Likhodi O; Kennedy JL; Müller DJ
World J Biol Psychiatry; 2011 Aug; 12(5):392-7. PubMed ID: 21767209
[TBL] [Abstract][Full Text] [Related]
6. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
Ferreira MA; O'Donovan MC; Meng YA; Jones IR; Ruderfer DM; Jones L; Fan J; Kirov G; Perlis RH; Green EK; Smoller JW; Grozeva D; Stone J; Nikolov I; Chambert K; Hamshere ML; Nimgaonkar VL; Moskvina V; Thase ME; Caesar S; Sachs GS; Franklin J; Gordon-Smith K; Ardlie KG; Gabriel SB; Fraser C; Blumenstiel B; Defelice M; Breen G; Gill M; Morris DW; Elkin A; Muir WJ; McGhee KA; Williamson R; MacIntyre DJ; MacLean AW; St CD; Robinson M; Van Beck M; Pereira AC; Kandaswamy R; McQuillin A; Collier DA; Bass NJ; Young AH; Lawrence J; Ferrier IN; Anjorin A; Farmer A; Curtis D; Scolnick EM; McGuffin P; Daly MJ; Corvin AP; Holmans PA; Blackwood DH; Gurling HM; Owen MJ; Purcell SM; Sklar P; Craddock N;
Nat Genet; 2008 Sep; 40(9):1056-8. PubMed ID: 18711365
[TBL] [Abstract][Full Text] [Related]
7. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males.
Roussos P; Giakoumaki SG; Georgakopoulos A; Robakis NK; Bitsios P
Bipolar Disord; 2011 May; 13(3):250-9. PubMed ID: 21676128
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data.
Fiorentino A; O'Brien NL; Locke DP; McQuillin A; Jarram A; Anjorin A; Kandaswamy R; Curtis D; Blizard RA; Gurling HM
Bipolar Disord; 2014 Sep; 16(6):583-91. PubMed ID: 24716743
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of SNPs in CACNA1C and ANK3 gene with schizophrenia: A comprehensive meta-analysis.
Nie F; Wang X; Zhao P; Yang H; Zhu W; Zhao Y; Chen B; Valenzuela RK; Zhang R; Gallitano AL; Ma J
Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):637-48. PubMed ID: 26227746
[TBL] [Abstract][Full Text] [Related]
10. Association of CACNA1C with bipolar disorder among the Pakistani population.
Khalid M; Driessen TM; Lee JS; Tejwani L; Rasool A; Saqlain M; Shiaq PA; Hanif M; Nawaz A; DeWan AT; Raja GK; Lim J
Gene; 2018 Jul; 664():119-126. PubMed ID: 29684488
[TBL] [Abstract][Full Text] [Related]
11. Allelic expression imbalance of the schizophrenia susceptibility gene CHI3L1: evidence of cis-acting variation and tissue specific regulation.
Hill MJ; Kenny E; Roche S; Morris DW; Corvin A; Hawi Z; Gill M; Anney RJ
Psychiatr Genet; 2011 Dec; 21(6):281-6. PubMed ID: 21642896
[TBL] [Abstract][Full Text] [Related]
12. CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder.
Jakobsson J; Pålsson E; Sellgren C; Rydberg F; Ekman A; Zetterberg H; Blennow K; Landén M
Br J Psychiatry; 2016 Feb; 208(2):195-6. PubMed ID: 26541689
[TBL] [Abstract][Full Text] [Related]
13. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample.
Green EK; Hamshere M; Forty L; Gordon-Smith K; Fraser C; Russell E; Grozeva D; Kirov G; Holmans P; Moran JL; Purcell S; Sklar P; Owen MJ; O'Donovan MC; Jones L; ; Jones IR; Craddock N
Mol Psychiatry; 2013 Dec; 18(12):1302-7. PubMed ID: 23070075
[TBL] [Abstract][Full Text] [Related]
14. ANK3 gene expression in bipolar disorder and schizophrenia.
Wirgenes KV; Tesli M; Inderhaug E; Athanasiu L; Agartz I; Melle I; Hughes T; Andreassen OA; Djurovic S
Br J Psychiatry; 2014 Sep; 205(3):244-5. PubMed ID: 24809399
[TBL] [Abstract][Full Text] [Related]
15. Cognitive effects of the ANK3 risk variants in patients with bipolar disorder and healthy individuals.
Hori H; Yamamoto N; Teraishi T; Ota M; Fujii T; Sasayama D; Matsuo J; Kinoshita Y; Hattori K; Nagashima A; Ishida I; Koga N; Higuchi T; Kunugi H
J Affect Disord; 2014 Apr; 158():90-6. PubMed ID: 24655771
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons.
Lim JE; Pinsonneault J; Sadee W; Saffen D
Mol Psychiatry; 2007 May; 12(5):491-501. PubMed ID: 17453063
[TBL] [Abstract][Full Text] [Related]
17. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries.
Williams HJ; Craddock N; Russo G; Hamshere ML; Moskvina V; Dwyer S; Smith RL; Green E; Grozeva D; Holmans P; Owen MJ; O'Donovan MC
Hum Mol Genet; 2011 Jan; 20(2):387-91. PubMed ID: 21037240
[TBL] [Abstract][Full Text] [Related]
18. Cis-acting regulation of brain-specific ANK3 gene expression by a genetic variant associated with bipolar disorder.
Rueckert EH; Barker D; Ruderfer D; Bergen SE; O'Dushlaine C; Luce CJ; Sheridan SD; Theriault KM; Chambert K; Moran J; Purcell SM; Madison JM; Haggarty SJ; Sklar P
Mol Psychiatry; 2013 Aug; 18(8):922-9. PubMed ID: 22850628
[TBL] [Abstract][Full Text] [Related]
19. Candidate gene associations with mood disorder, cognitive vulnerability, and fronto-limbic volumes.
Frazier TW; Youngstrom EA; Frankel BA; Zunta-Soares GB; Sanches M; Escamilla M; Nielsen DA; Soares JC
Brain Behav; 2014 May; 4(3):418-30. PubMed ID: 24944871
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals.
Franke B; Vasquez AA; Veltman JA; Brunner HG; Rijpkema M; Fernández G
Biol Psychiatry; 2010 Sep; 68(6):586-8. PubMed ID: 20638048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
